Lexaria Bioscience Corp (NASDAQ:LEXX)
| 0.7352 Delayed Data As of Jun 06 |  -0.0248 / -3.26%Today’s Change | 0.65 Today|||52-Week Range 3.60 | -70.11% Year-to-Date |
Latest LEXX News | Press Releases
No recent news for Lexaria Bioscience Corp.
Today’s Trading
| Previous close | 0.76 |
| Today’s open | 0.74 |
| Day’s range | 0.74 - 0.74 |
| Volume | 100 |
| Average volume (3 months) | 104,189 |
| Market cap | -- |
Data as of 12:42pm ET, 06/06/2023
Growth & Valuation
| Earnings growth (last year) | -34.70% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -64.66% |
| P/E ratio | NM |
| Price/Sales | 68.21 |
| Price/Book | -- |
Competitors
| ---- | ||
| LNLHFLeanLife Health Inc | 0.00 | 0.00% |
| SUWNSunwin Stevia Intern... | 0.00 | 0.00% |
| --Protein Reactor Comb... | 0.00 | 0.00% |
Data as of 06/01/2023
Financials
| Next reporting date | July 14, 2023 |
| EPS forecast (this quarter) | -$0.28 |
| Annual revenue (last year) | $255.4K |
| Annual profit (last year) | -$7.3M |
| Net profit margin | -2,846.28% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Kelowna, British Columbia |
Forecasts
